
Concentration movements in recent years have involved Nestle (a $12 billion purchase of Pfizer’s infant nutrition business in 2012), Lactalis (control of Italian Parmalat in 2012-2016), Mexico’s Grupo Lala Invalid tag asset (for U.S. assets from Laguna Dairy in 2016), Reckitt Benkiser
The price squeeze has also prompted some major producers, such as Irish Glanbia
